Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2010 2
2012 1
2013 2
2014 1
2015 1
2016 1
2017 1
2019 2
2020 1
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis.
Coughlan JJ, Aytekin A, Lahu S, Scalamogna M, Wiebe J, Pinieck S, Kufner S, Xhepa E, Joner M, Kuna C, Voll F, Laugwitz KL, Schunkert H, Kastrati A, Cassese S. Coughlan JJ, et al. Among authors: pinieck s. EuroIntervention. 2023 Apr 3;18(16):e1328-e1338. doi: 10.4244/EIJ-D-22-00860. EuroIntervention. 2023. PMID: 36785947 Free PMC article. Clinical Trial.
Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis.
Xhepa E, Bresha J, Joner M, Hapfelmeier A, Rivero F, Ndrepepa G, Nano N, Cuesta J, Kufner S, Cassese S, Bastante T, Aytekin A, Rroku A, García-Guimaraes M, Lahmann AL, Pinieck S, Rai H, Fusaro M, Schunkert H, Pérez-Vizcayno MJ, Gonzalo N, Alfonso F, Kastrati A. Xhepa E, et al. Among authors: pinieck s. EuroIntervention. 2021 Aug 6;17(5):e388-e395. doi: 10.4244/EIJ-D-20-00662. EuroIntervention. 2021. PMID: 32894230 Free PMC article.
Optical Coherence Tomography Tissue Coverage and Characterization with Grey-Scale Signal Intensity Analysis After Bifurcation Stenting with a New Generation Bioabsorbable Polymer Drug-Eluting Stent.
Rai H, Hussein H, Colleran R, Xhepa E, Wiebe J, Pinieck S, Cassese S, Joner M, Kastrati A, Byrne RA, Foley DP. Rai H, et al. Among authors: pinieck s. Cardiovasc Revasc Med. 2020 Mar;21(3):277-285. doi: 10.1016/j.carrev.2019.05.004. Epub 2019 May 8. Cardiovasc Revasc Med. 2020. PMID: 31155492
Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique.
Harada Y, Colleran R, Pinieck S, Giacoppo D, Michel J, Kufner S, Cassese S, Joner M, Ibrahim T, Laugwitz KL, Kastrati A, Byrne RA. Harada Y, et al. Among authors: pinieck s. EuroIntervention. 2017 Apr 20;12(17):2132-2139. doi: 10.4244/EIJ-D-16-00226. EuroIntervention. 2017. PMID: 27916742 Free article.
Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial.
Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz KL, Massberg S, Kastrati A; ISAR-DESIRE 3 investigators. Byrne RA, et al. Among authors: pinieck s. Lancet. 2013 Feb 9;381(9865):461-7. doi: 10.1016/S0140-6736(12)61964-3. Epub 2012 Dec 1. Lancet. 2013. PMID: 23206837 Clinical Trial.
13 results